Skip to main content
SpringerLink
Log in

Folic acid and its congeners in the treatment of schizophrenia

  • Letter to the Editor
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Anderson OS, Sant KE, Dolinoy DC (2012) Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism, and DNA methylation. J Nutr Biochem 23:853–859

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Godfrey PS, Toone BK, Carney MW, Flynn TG, Bottiglieri T, Laundy M, Chanarin I, Reynolds EH (1990) Enhancement of recovery from psychiatric illness by methylfolate. Lancet 336:392–395

    Article  CAS  PubMed  Google Scholar 

  • Kaushansky K, Kipps TJ (2018) Hematopoietic agents: growth factors, minerals, and vitamins. In: The PHARMACOLOGICAL BASIS OF THERAPEUTICS, eds. Brunton LL, Hilal-Dandan R, Knollmann BC, McGraw-Hill: New York, 751–767

  • Mathews RG (2002) Methylenetetrahydrofolate reductase: a common human polymorphism and its biochemical implications. Chem Record 2:4–12

    Article  CAS  Google Scholar 

  • Muntjewerff JW, Kahn RS, Blom HJ, den Heijer M (2006) Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry 11:143–149

    Article  CAS  PubMed  Google Scholar 

  • Peedicayil J (2012) Role of epigenetics in pharmacotherapy, psychotherapy and nutritional management of mental disorders. J Clin Pharm Ther 37:499–501

    Article  CAS  PubMed  Google Scholar 

  • Roffman JL, Petruzzi LJ, Tanner AS, Brown HE, Eryilmaz H, Ho NF, Giegold M, Silverstein NJ, Bottiglieri T, Manoach DS, Smoller JW, Henderson DC, Goff DC (2018) Biochemical, physiologic, and clinical effects of L-methylfolate in schizophrenia: a randomized controlled trial. Mol Psychiatry 23:316–322

    Article  CAS  PubMed  Google Scholar 

  • Sakuma K, Matsunaga S, Nomura I, Okuya M, Kishi T, Iwata N (2018) Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis. Psychopharmacology 235:2303–2314

    Article  CAS  PubMed  Google Scholar 

  • Stahl SM (2008) L-methylfolate: a vitamin for your monoamines. J Clin Psychiatry 69:1352–1353

    Article  CAS  PubMed  Google Scholar 

  • Yadav U, Kumar P, Gupta S, Rai V (2016) Role of MTHFR C677T gene polymorphism in the susceptibility of schizophrenia: an updated meta-analysis. Asian J Psychiatr 20:41–51

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Clinical Pharmacology, Christian Medical College, Vellore, India

    Jacob Peedicayil

Authors
  1. Jacob Peedicayil
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacob Peedicayil.

Ethics declarations

Conflicts of interest

The author declares that there is no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peedicayil, J. Folic acid and its congeners in the treatment of schizophrenia. Psychopharmacology 236, 1401–1402 (2019). https://doi.org/10.1007/s00213-018-5095-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-018-5095-1

Search

Navigation